Targeting HMGB3/hTERT axis for radioresistance in cervical cancer.
Li Z, Zhang Y, Sui S, Hua Y, Zhao A, Tian X, Wang R, Guo W, Yu W, Zou K, Deng W, He L, Zou L.
Li Z, et al.
J Exp Clin Cancer Res. 2020 Nov 13;39(1):243. doi: 10.1186/s13046-020-01737-1.
J Exp Clin Cancer Res. 2020.
PMID: 33187536
Free PMC article.